Elsevier Inc.

SHERPA: Unknown

People

  1. Giralt
    Giralt
  2. Scordo
    Scordo
  3. Maclachlan
    Maclachlan
  4. Landau
    Landau
  5. Lesokhin
    Lesokhin
  6. Shah
    Shah
  7. Usmani
    Usmani
  8. Mailankody
    Mailankody
  9. Drilon
    Drilon
  10. Hassoun
    Hassoun

Groups

  1. Hematology-Oncology Fellows (136)
  2. Department of Medicine (111)
  3. Graduate Medical Education (104)
  4. GME, Medicine (100)
  5. Weinberg Fellows (72)
  6. Solid Tumor Oncology Division (66)
  7. Hematologic Malignancies, Division of (65)
  8. Sloan Kettering Institute Postdocs (52)
  9. Center for Hematologic Malignancies (50)
  10. GSK Faculty (44)
Search Within
  1. "Hematology-Oncology Fellows"
Formats
  1. Meeting Abstract (71)
  2. Journal Article (38)
  3. Review (19)
  4. Editorial (5)
  5. Correspondence (2)
  6. Research Letter (1)
Groups
  1. Hematology-Oncology Fellows (136)
  2. Department of Medicine (111)
  3. Graduate Medical Education (104)
  4. GME, Medicine (100)
  5. Weinberg Fellows (72)
  6. Solid Tumor Oncology Division (66)

More Groups

People
  1. Sergio Giralt (18)
  2. Michael Scordo (16)
  3. David Chung (15)
  4. Kylee Maclachlan (15)
  5. Alexander Lesokhin (14)
  6. Gunjan Shah (14)

More People

Years
  1. 2025 (11)
  2. 2024 (36)
  3. 2023 (26)
  4. 2022 (16)
  5. 2021 (15)
  6. 2020 (11)

More Years

Publications
  1. Journal of Thoracic Oncology (30)
  2. Clinical Lymphoma, Myeloma and Leukemia (18)
  3. International Journal of Radiation Oncology, Biology, Physics (15)
  4. Biology of Blood and Marrow Transplantation (14)
  5. Gynecologic Oncology (12)
  6. Transplantation and Cellular Therapy (9)

More Publications

Results (136)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecularly targeted therapies for triple negative breast cancer: History, advances, and future directions
    Review

    Mai, N.; Abuhadra, N.; Jhaveri, K.
    Clinical Breast Cancer (2023)

    Fulltext@MSK | Save
  • Barriers to early detection: Insurance denials for breast MRI screening in women with germline BRCA1/2
    Meeting Abstract

    Gordhandas, S.; Yen, T. T.; Ingber, S.; Kahn, R.; Kayani, S.; Taffuri, A.; Sokolowski, S.; Martinez, D.; Garcia, P.; Mullangi, S.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Oncolytic immunotherapy with recombinant Newcastle disease virus-encoding interleukin-12 in ovarian cancer mouse models
    Meeting Abstract

    Kahn, R.; Green, H.; Pesci, G.; Burman, B.; Praiss, A.; Ozsoy, M.; Brodeur, M.; Bhaloo, S. I.; Abu-Rustum, N.; Chi, D.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Clinical significance of baseline body mass index and its trajectory during triplet induction therapy in newly diagnosed multiple myeloma
    Meeting Abstract

    Thirugnanasambandam, R. P.; Firestone, R.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Mailankody, S.; Lahoud, O.; Landau, H.; Chung, D.; Shah, G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Patterns of cytokine release syndrome with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy
    Meeting Abstract

    Hamadeh, I.; Shekarkhand, T.; Rueda, C.; Firestone, R.; Wang, A.; Korde, N.; Hultcrantz, M.; Lesokhin, A.; Mailankody, S.; Hassoun, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Bispecific T-cell engager response is driven by pre-treatment CD8+ effector memory cells and inhibited by TIGIT+ Tregs in relapsed/refractory multiple myeloma
    Meeting Abstract

    Firestone, R.; McAvoy, D.; Shekarkhand, T.; Serrano, E.; Hamadeh, I.; Wang, A.; Zhu, M.; Patel, D.; Tan, C. R.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • SVR (spleen volume reduction) predicts OS (overall survival) in MF (myelofibrosis) patients on PAC (pacritinib) but not BAT (best available therapy): PERSIST-2 landmark OS analysis
    Meeting Abstract

    Ajufo, H.; Bewersdorf, J. P.; Harrison, C.; Palandri, F.; Mascarenhas, J.; Palmer, J.; Gerds, A.; Kiladjian, J. J.; Buckley, S.; Derkach, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Frequency and outcomes of leptomeningeal metastases in patients with fusion-positive lung cancers
    Meeting Abstract

    Chen, M.; Sui, J.; Wilcox, J.; Yang, S. R.; Imber, B.; Offin, M.; Yu, H.; Kris, M. G.; Drilon, A. E.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Beware: Tyrosine kinase inhibitors for lung cancers that inhibit MATE-1 can lead to "False" decreases in renal function
    Meeting Abstract

    Chen, M.; Harada, G.; Liu, D.; Dematteo, R.; Falcon, C.; Wilhelm, C.; Kris, M. G.; Drilon, A. E.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Brain metastases in patients with fusion-positive lung cancers
    Meeting Abstract

    Sui, J. S.; Chen, M. F.; Wilcox, J.; Yang, S. R.; Li, B. T.; Riely, G. J.; Offin, M.; Yu, H. A.; Kris, M. G.; Drilon, A. E.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save